Related Experiment Video
Updated: Jun 21, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers
1Cancer Epigenetics Laboratory, State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Shatin, Hong Kong.
Abstract:
Aberrant activation of the WNT/beta-catenin signaling pathway is frequently involved in a broad spectrum of human malignancies. Alternative to genetic deletions and point mutations, epigenetic inactivation of negative WNT regulators, through DNA methylation of promoter CpG islands and/or histone modification, leads to the activation or amplification of aberrant WNT/beta-catenin signaling. In this review, we summarized the contribution of epigenetic dysregulation of WNT/beta-catenin signaling to tumorigenesis and highlighted the importance of epigenetic identification of negative regulators of this pathway as putative tumor suppressors. The reversal of these silenced regulators may be developed as potential cancer therapeutics.
Insights
Epigenetic silencing of WNT pathway regulators promotes cancer. Identifying and reversing these epigenetic changes offers potential new cancer therapies.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Aberrant WNT/beta-catenin signaling is a hallmark of many human cancers.
- Epigenetic mechanisms, including DNA methylation and histone modification, can silence negative WNT regulators.
- This silencing contributes to uncontrolled WNT/beta-catenin pathway activation in tumorigenesis.
Purpose of the Study:
- To review the role of epigenetic dysregulation in WNT/beta-catenin signaling in cancer.
- To highlight the significance of epigenetically silenced negative WNT regulators as potential tumor suppressors.
- To discuss the therapeutic potential of reversing these epigenetic silencing events.
Main Methods:
- Literature review focusing on epigenetic mechanisms affecting WNT signaling.
- Analysis of studies linking DNA methylation and histone modifications to WNT pathway dysregulation.
- Synthesis of evidence on the tumor suppressor roles of epigenetically silenced WNT regulators.
Main Results:
- Epigenetic inactivation of negative WNT regulators is a key driver of aberrant WNT/beta-catenin signaling in various cancers.
- These silenced regulators function as tumor suppressors.
- Re-expression of these silenced genes presents a promising therapeutic strategy.
Conclusions:
- Epigenetic dysregulation of the WNT/beta-catenin pathway is crucial in cancer development.
- Targeting epigenetic modifications of WNT regulators offers a novel therapeutic avenue.
- Further research into identifying and reactivating these silenced tumor suppressors is warranted for cancer treatment.
More Related Videos
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
